Understanding the diagnostic process for multiple sclerosis.
As we all know, MS is difficult to diagnose. Put another way, it’s easy to misdiagnose.
There’s no single diagnostic test for MS. Neurologists use their clinical examination, the patient’s medical history, and lab tests. They also rely on MRI imaging of the brain and sometimes of the spinal cord. These tests are intended to rule out other possible causes of a person’s neurological symptoms and gather data that would point to an MS diagnosis. If it appears that MS is likely, a spinal tap might be ordered as further confirmation.
All of these tests are run under a protocol called the McDonald Criteria. It’s used when a patient is experiencing what doctors call clinically isolated syndrome, or CIS. CIS is the appearance of neurological symptoms that are typical of MS in a person who hasn’t been diagnosed with MS.
Hoping to speed up the diagnostic process and improve its accuracy, old McDonald has just been updated. The basic changes, published in The Lancet Neurology, include lowering the threshold for ordering a spinal tap and allowing doctors to consider that lesions they can see on an MRI might be caused by MS even if they aren’t actually producing physical symptoms.
The revised McDonald Criteria
A panel of 30 international MS experts wrote the revision. Importantly, in my opinion, that panel says MS is best diagnosed by a clinician with MS-related expertise, supported by imaging and other tests. (Too often, I believe, the doctor trying to make the diagnosis lacks that expertise.) The experts recommend that a brain MRI should be obtained, if at all possible, during the MS diagnostic process. A spinal MRI also should be obtained when additional data are needed to confirm the diagnosis.
After that, according to the updated McDonald Criteria, here are the major things to be considered when making a diagnosis of multiple sclerosis:
- Oligoclonal bands — These are bands of proteins that are related to inflammation in the central nervous system. Positive findings of oligoclonal bands in the spinal fluid can now substitute, in making the diagnosis, for the appearance of spinal column lesions that have been seen on multiple MRIs.
- Types of lesions — Both asymptomatic and now symptomatic MRI lesions can be used when determining that lesions have appeared in both space or time. (“In space” is an indication of damage in more than one location in the nervous system. “In time” indicates that damage has occurred more than once.)
- Site of lesions — Cortical lesions in the brain have been added to juxtacortical (next to the cortex) lesions for use in meeting MRI criteria for dissemination of lesions in space.
- An essential diagnosis consideration must be that there is no better explanation for the symptoms and test results than a diagnosis of MS.
The panel also recommended that:
- When spinal fluid is used as part of the diagnostic process, that fluid should be compared with a blood sample to confirm that oligoclonal bands appear only in the spinal fluid. If the bands also appear in the blood, an MS diagnosis is notappropriate.
- An MS diagnosis can be made without having to indicate whether the course of the disease is active or not, and progressive or not. The type and course of the disease should be re-evaluated periodically.
Read full article: Diagnosing MS Faster and Better – Multiple Sclerosis News Today
|Read Full Article: Diagnosing MS Faster and Better – Multiple Sclerosis News Today|